Clinical Trial Update: Effect of Imatinib in Advance Liver Fibrosis Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on the effect of imatinib in patients with advanced liver fibrosis, currently in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Research Institute for Gastroenterology and Liver Diseases (RIGLD) | Conditions: Liver Fibrosis | Phase 1, Phase 2 | Status: UNKNOWN